Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 975

Sort by

Sort Order Select

Journal Articles

Prognostic factors for CNS control in children with acute lymphoblastic leukemia treated without cranial irradiation

Blood (2021) 138 (4): 331–343.

https://doi.org/10.1182/blood.2020010438

Published: 2021

Includes: Supplemental data

Journal Articles

Genomic predictors of central nervous system relapse in primary testicular diffuse large B-cell lymphoma

David D. W. Twa, Derrick G. Lee, King L. Tan, Graham W. Slack, Susana Ben-Neriah, Diego Villa, Joseph M. Connors, Laurie H. Sehn, Anja Mottok, Randy D. Gascoyne, David W. Scott, Christian Steidl, Kerry J. Savage

Blood (2021) 137 (9): 1256–1259.

https://doi.org/10.1182/blood.2020006338

Published: 2021

Includes: Supplemental data

Journal Articles

Genomic subtypes may predict the risk of central nervous system recurrence in diffuse large B-cell lymphoma

Thomas A. Ollila, Habibe Kurt, Jozal Waroich, John Vatkevich, Ashlee Sturtevant, Nimesh R. Patel, Patrycja M. Dubielecka, Diana O. Treaba, Adam J. Olszewski

Blood (2021) 137 (8): 1120–1124.

https://doi.org/10.1182/blood.2020007236

Published: 2021

Includes: Supplemental data

Journal Articles

Pediatric hemophagocytic lymphohistiocytosis

Scott W. Canna, Rebecca A. Marsh

Blood (2020) 135 (16): 1332–1343.

https://doi.org/10.1182/blood.2019000936

Published: 2020

Journal Articles

Erdheim-Chester disease

Julien Haroche, Fleur Cohen-Aubart, Zahir Amoura

Blood (2020) 135 (16): 1311–1318.

https://doi.org/10.1182/blood.2019002766

Published: 2020

Journal Articles

Evaluation of Biomarkers As Predictors of Blinatumomab Toxicity and Real-World Management of Blinatumomab Toxicity in B-Acute Lymphoblastic Leukemia Patients

Amber C. King, PharmD, BCOP, Jae H. Park, MD, Mark B. Geyer, MD

Blood (2019) 134 (Supplement_1): 3887.

https://doi.org/10.1182/blood-2019-128506

Published: 2019

Journal Articles

MEK Inhibition with Trametinib in Patients with Non-Langerhans Cell Histiocytosis

Filip Janku, MD PhD, Harsh Patel, BS, Vaijayanthi Kandadai Raghavan, Aaron Goodman, Tamara G. Barnes, Razelle Kurzrock, MD

Blood (2019) 134 (Supplement_1): 2319.

https://doi.org/10.1182/blood-2019-126342

Published: 2019

Journal Articles

Characteristics of Children with Abnormal TCD in the Modern Era: Results from the Displace Consortium

Julie Kanter, MD, Mary Dooley, MS, Logan P Sirline, MPH, Martina Mueller, PhD, Shannon Phillips, PhD RN, Alyssa M Schlenz, PhD, Cathy Melvin, PhD MPH, Robert J. Adams, MD MS

Blood (2019) 134 (Supplement_1): 2270.

https://doi.org/10.1182/blood-2019-129951

Published: 2019

Journal Articles

Clinical and Laboratory Features Associated with Flow Cytometric CD49f Expression in Pediatric B Cell Acute Lymphoblastic Leukemia

Eric McGinnis, MD BSc, David Yang, BMLSc, Nina Rolf, MD PhD, Gregor S. D. Reid, PhD, Chinten J. Lim, PhD, Suzanne M. Vercauteren, MD PhD FRCPC

Blood (2019) 134 (Supplement_1): 5209.

https://doi.org/10.1182/blood-2019-123590

Published: 2019

Journal Articles

Outcome of Atypical Presentations of Hairy Cell Leukemia

Afraa Moustafa, MD, Hawraa M Shwaylia, MD, Mahmood Aldapt, MD, Mohamed A Yassin, MBBS, MSc

Blood (2019) 134 (Supplement_1): 5267.

https://doi.org/10.1182/blood-2019-121826

Published: 2019

Journal Articles

The Magnitude of Lactate Dehydrogenase Elevation As a Predictive Factor for Central Nervous System Relapse in Diffuse Large B-Cell Lymphoma

Iolanda Vieira, Miguel Quintela, Cláudia Moreira, Sérgio Chacim, Nelson Domingues, Isabel Oliveira, Ana Espirito Santo, Maria Ilidia Moreira, Ângelo Martins, Maria Luisa Viterbo, Dulcineia Pereira, Jose Mario Mariz

Blood (2019) 134 (Supplement_1): 5342.

https://doi.org/10.1182/blood-2019-130993

Published: 2019

Journal Articles

Risk Factors for Central Nervous System (CNS) Relapse after Autologous Stem Cell Transplant (ASCT) in Diffuse Large B-Cell Lymphoma (DLBCL)

Yukie Terasaki, MD, Hiroaki Shimizu, MD PhD, Yuri Miyazawa, MD PhD, Kohtaro Toyama, MD PhD, Hiromi Koiso, MD PhD, Akihiko Yokohama, MD PhD, Morio Matsumoto, MD, Hidemi Ogura, Chiaki Naito, MD, Norifumi Tsukamoto, MD PhD, Hiroshi Handa, MD PhD

Blood (2019) 134 (Supplement_1): 5344.

https://doi.org/10.1182/blood-2019-127990

Published: 2019

Journal Articles

Extranodal NK/T Cell Lymphoma Nasal Type: A Cohort Study from Latin America

Lidiane Inês Da Rosa, MD, Wellington Fernandes da Silva, MD, Andre Abdo, MD, Eduardo M Rego, MD PhD, Vanderson Rocha, MD PhD, Juliana Pereira, MD PhD

Blood (2019) 134 (Supplement_1): 5284.

https://doi.org/10.1182/blood-2019-126307

Published: 2019

Journal Articles

A Phase 2, Randomized, Open-Label, 2-Arm Study Comparing 2 Intermittent Dosing Schedules of Duvelisib in Patients with Indolent Non-Hodgkin Lymphoma (iNHL) (TEMPO)

Reem Karmali, MD, Hagop Youssoufian, MD, Kam Sprott, PhD, David T. Weaver, PhD, Narayana Narasimhan, Stephanie Lustgarten, PhD, Gloria Patrick, Alena Zalutskaya, Leo I. Gordon, MD

Blood (2019) 134 (Supplement_1): 5251.

https://doi.org/10.1182/blood-2019-124406

Published: 2019

Journal Articles

Quality of Life in Patients with Multiple Sclerosis after Autologous Hematopoietic Stem Cell Transplantation

Juan Carlos Olivares-Gazca, MD, Iván Murrieta-Álvarez, MD, Jesús Mauricio Olivares-Gazca, MD, Yarely Itzayana García-Navarrete, MD, Yahveth Cantero-Fortiz, MD, Andrés A. León-Peña, MD, Guillermo J. Ruiz-Delgado, MD FACP, Guillermo J. Ruiz-Arguelles, FRCP, MACP

Blood (2019) 134 (Supplement_1): 5708.

https://doi.org/10.1182/blood-2019-129031

Published: 2019

Journal Articles

Incidence and Outcomes of Extramedullary Myeloma in a South Australian Hospital

Angelina Yong, BSc,BMBS, FRACP, FRCPA

Blood (2019) 134 (Supplement_1): 5504.

https://doi.org/10.1182/blood-2019-129754

Published: 2019

Journal Articles

Extramedullary Relapses after Allogeneic Stem Cell Transplant (allo-SCT) in Adult Patients with Acute Lymphoblastic Leukemia (ALL)

Hiroaki Shimizu, MD PhD, Takuma Ishizaki, MD PhD, Nahoko Hatsumi, MD, Satoru Takada, MD, Akihiko Yokohama, MD PhD, Takayuki Saitoh, MD PhD, Toru Sakura, PhD MD, Hiroshi Handa, MD PhD

Blood (2019) 134 (Supplement_1): 5690.

https://doi.org/10.1182/blood-2019-130590

Published: 2019

Journal Articles

Assessing Steroid Toxicity in the Elderly with Multiple Myeloma

Vidhya Nair, DO, Hadi Mohammed, MD, Sharmeen Mahmood, DO, Pushpinderdeep Singh Kahlon, MD, Philip Kuriakose, MD

Blood (2019) 134 (Supplement_1): 5557.

https://doi.org/10.1182/blood-2019-125442

Published: 2019

Journal Articles

Classification and Prognosis of Central Nervous System Involvement in Erdheim-Chester Disease

Fleur Cohen-Aubart, MD PhD, Ahmed Idbaih, MD PhD, Damien Galanaud, MD PhD, Bruno Law-Ye, MD, Jean-François Emile, MD PhD, Frédéric Charlotte, MD, Jean Donadieu, MD PhD, Zahir Amoura, MD MSc, Julien Haroche

Blood (2019) 134 (Supplement_1): 4272.

https://doi.org/10.1182/blood-2019-130606

Published: 2019

Journal Articles

Progression of Central Nervous System Vasculopathy in Young Adults with Sickle Cell Anemia

Grace Champlin, MD, Scott Hwang, MD PhD, Guolian Kang, PhD, Juan Ding, PhD, Jeremie H. Estepp, MD, Kenneth I. Ataga, MD, Curtis L. Owens, MD, Justin Newman, MD, Lisa M. Jacola, PhD ABPP-CN, Allison A. King, MD MPH, PhD, Robert Davis, MD MPH, Winfred Wang, MD, Jane S. Hankins, MD MS

Blood (2019) 134 (Supplement_1): 2290.

https://doi.org/10.1182/blood-2019-129193

Published: 2019

Update search

NARROW

Publications

Format

Subjects

Article Type

Topics

Date

Availability

Prognostic factors for CNS control in children with acute lymphoblastic leukemia treated without cranial irradiation

Genomic predictors of central nervous system relapse in primary testicular diffuse large B-cell lymphoma

Genomic subtypes may predict the risk of central nervous system recurrence in diffuse large B-cell lymphoma

Pediatric hemophagocytic lymphohistiocytosis

Erdheim-Chester disease

Evaluation of Biomarkers As Predictors of Blinatumomab Toxicity and Real-World Management of Blinatumomab Toxicity in B-Acute Lymphoblastic Leukemia Patients

MEK Inhibition with Trametinib in Patients with Non-Langerhans Cell Histiocytosis

Characteristics of Children with Abnormal TCD in the Modern Era: Results from the Displace Consortium

Clinical and Laboratory Features Associated with Flow Cytometric CD49f Expression in Pediatric B Cell Acute Lymphoblastic Leukemia

Outcome of Atypical Presentations of Hairy Cell Leukemia

The Magnitude of Lactate Dehydrogenase Elevation As a Predictive Factor for Central Nervous System Relapse in Diffuse Large B-Cell Lymphoma

Risk Factors for Central Nervous System (CNS) Relapse after Autologous Stem Cell Transplant (ASCT) in Diffuse Large B-Cell Lymphoma (DLBCL)

Extranodal NK/T Cell Lymphoma Nasal Type: A Cohort Study from Latin America

A Phase 2, Randomized, Open-Label, 2-Arm Study Comparing 2 Intermittent Dosing Schedules of Duvelisib in Patients with Indolent Non-Hodgkin Lymphoma (iNHL) (TEMPO)

Quality of Life in Patients with Multiple Sclerosis after Autologous Hematopoietic Stem Cell Transplantation

Incidence and Outcomes of Extramedullary Myeloma in a South Australian Hospital

Extramedullary Relapses after Allogeneic Stem Cell Transplant (allo-SCT) in Adult Patients with Acute Lymphoblastic Leukemia (ALL)

Assessing Steroid Toxicity in the Elderly with Multiple Myeloma

Classification and Prognosis of Central Nervous System Involvement in Erdheim-Chester Disease

Progression of Central Nervous System Vasculopathy in Young Adults with Sickle Cell Anemia

Email alerts

ASH Publications

American Society of Hematology

Update search

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only